These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37725027)

  • 41. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers.
    Pess GM; Pess RM; Pess RA
    J Hand Surg Am; 2012 Apr; 37(4):651-6. PubMed ID: 22464232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A
    Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
    J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dupuytren Disease: Is Collagenase Better Than Needling?: Commentary on an article by Joakim Strömberg, MD, et al.: "Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture. A Randomized Controlled Trial with a Two-Year Follow-up".
    Slater RR
    J Bone Joint Surg Am; 2018 Jul; 100(13):e91. PubMed ID: 29975278
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture.
    Wiwanitkit V
    J Hand Surg Am; 2012 Feb; 37(2):394; author reply 394-5. PubMed ID: 22281175
    [No Abstract]   [Full Text] [Related]  

  • 45. Collagenase enzymatic fasciotomy for Dupuytren contracture in patients on chronic immunosuppression.
    Waters MJ; Belsky MR; Blazar PE; Leibman MI; Ruchelsman DE
    Am J Orthop (Belle Mead NJ); 2015 Nov; 44(11):518-21. PubMed ID: 26566553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
    Badalamente MA; Hurst LC; Benhaim P; Cohen BM
    J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 10-Year Review of Collagenase Versus Fasciectomy in the Treatment of Dupuytren Contracture.
    Steppe C; Cinclair R; Lies S
    Ann Plast Surg; 2024 Jun; 92(6):642-646. PubMed ID: 38717148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Collagenase Tenotomy for Dupuytren Boutonniere.
    Denkler KA; Vaughn CJ; Park KM; Hansen SL
    Plast Reconstr Surg; 2021 Nov; 148(5):764e-768e. PubMed ID: 34705780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical Management of Dupuytren Disease: A Systematic Review and Network Meta-analyses.
    Nann S; Kovoor J; Fowler J; Kieu J; Gupta A; Hewitt J; Ovenden C; Edwards S; Bacchi S; Jacobsen JHW; Harries R; Maddern G
    Hand (N Y); 2023 May; ():15589447231174175. PubMed ID: 37246411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in Minimally Invasive Treatment of Dupuytren Disease.
    Hovius SER; Zhou C
    Hand Clin; 2018 Aug; 34(3):417-426. PubMed ID: 30012301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Outcomes of Dupuytren Disease Treatment.
    Binhammer P
    Hand Clin; 2018 Aug; 34(3):377-386. PubMed ID: 30012297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
    Smeraglia F; Del Buono A; Maffulli N
    Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.
    Baltzer H; Binhammer PA
    Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up.
    Watt AJ; Curtin CM; Hentz VR
    J Hand Surg Am; 2010 Apr; 35(4):534-9, 539.e1. PubMed ID: 20353858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimally invasive partial fasciectomy for Dupuytren contractures.
    Gelman SE; Schlenker R; Jacoby SM; Shin EK; Culp RW
    Tech Hand Up Extrem Surg; 2012 Dec; 16(4):184-6. PubMed ID: 23160547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New treatment options for Dupuytren's surgery: collagenase and percutaneous aponeurotomy.
    Srinivasan RC; Shah AS; Jebson PJ
    J Hand Surg Am; 2010 Aug; 35(8):1362-4. PubMed ID: 20434276
    [No Abstract]   [Full Text] [Related]  

  • 58. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions.
    Werker PM; Pess GM; van Rijssen AL; Denkler K
    J Hand Surg Am; 2012 Oct; 37(10):2095-2105.e7. PubMed ID: 22938804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Dupuytren's disease treatment].
    Kornø MR; Søe N; Dahlin LB
    Ugeskr Laeger; 2015 Mar; 177(11):. PubMed ID: 25786701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
    Zhou C; Hovius SER; Slijper HP; Feitz R; Van Nieuwenhoven CA; Pieters AJ; Selles RW
    Plast Reconstr Surg; 2015 Jul; 136(1):87-97. PubMed ID: 25829153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.